𝔖 Bobbio Scriptorium
✦   LIBER   ✦

An open label randomized multicentre phase IIIb trial comparing parenteral substitution versus best supportive nutritional care in subjects with pancreatic adenocarcinoma receiving 5-FU plus oxaliplatin as 2ndor higher line chemotherapy regarding clinical benefit - PANUSCO

✍ Scribed by Angela Märten; Moritz N Wente; Jennifer Ose; Markus W Büchler; Ingeborg Rötzer; Christiane Decker-Baumann; Irini Karapanagiotou-Schenkel; Sabine Harig; Jan Schmidt; Dirk Jäger


Book ID
115011756
Publisher
BioMed Central
Year
2009
Tongue
English
Weight
288 KB
Volume
9
Category
Article
ISSN
1471-2407

No coin nor oath required. For personal study only.